Starget Pharma
Updated: April 03, 2026
CEO - Sigal Kalmanson Cusnir
Country: Israel | Funding: $33.1M (+)
Founded: 2019
Website: https://stargetpharma.com/
Starget Pharma is developing a somatostatin-based targeted cancer therapy platform. It combines therapeutic drugs with radioactive isotopes, minimizing damage to healthy tissue. One of the key advantages of this approach is the use of the same molecular platform for both diagnosis and treatment: first, the molecule is administered along with a diagnostic isotope to assess tumor uptake using imaging. If imaging confirms strong tumor uptake, the same molecule is combined with a more potent therapeutic isotope to deliver targeted therapy. The own AI platform enables faster discovery and development of highly accurate radiopharmaceuticals. The company is conducting clinical trials of this technology for the treatment of sarcoma, skin cancer, liver cancer and neuroendocrine tumors.
Founded: 2019
Website: https://stargetpharma.com/
Starget Pharma is developing a somatostatin-based targeted cancer therapy platform. It combines therapeutic drugs with radioactive isotopes, minimizing damage to healthy tissue. One of the key advantages of this approach is the use of the same molecular platform for both diagnosis and treatment: first, the molecule is administered along with a diagnostic isotope to assess tumor uptake using imaging. If imaging confirms strong tumor uptake, the same molecule is combined with a more potent therapeutic isotope to deliver targeted therapy. The own AI platform enables faster discovery and development of highly accurate radiopharmaceuticals. The company is conducting clinical trials of this technology for the treatment of sarcoma, skin cancer, liver cancer and neuroendocrine tumors.
